PER 1.41% 7.0¢ percheron therapeutics limited

Chart, page-3333

  1. 79 Posts.
    lightbulb Created with Sketch. 10
    Seems like a non issue for ANP holders

    From Pharmaphorum.com - ”The company gave little else away but added that there were no new or emerging safety signals identified, meaning that the issue is likely to be that the drug simply wasn’t working in the placebo-controlled trial.”
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.